financetom
Business
financetom
/
Business
/
ASML sees AI demand as long-term growth driver in 2025 annual report
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
ASML sees AI demand as long-term growth driver in 2025 annual report
Mar 11, 2026 5:29 AM

AMSTERDAM, Feb 25 (Reuters) - ASML, the biggest supplier of lithography equipment used to make computer chips, said in its 2025 annual report published Wednesday it ​now sees the artificial intelligence ‌boom as the main driver for demand for its products.

The report reflects ⁠a change in tone from 2024, when the ⁠company emphasized that the semiconductor industry is ‌cyclical and ‌AI might prove a disappointment.

* "At first, we believed that AI would drive ​demand fromonly a limited ‌portion of our customer base. At the end of theyear, we saw that new and ​significant demand for AI ​was startingto ‌fuel capacity build-up across our broad customer base - apowerful trend that we believe will continue in ⁠2026 andbeyond," CEO Christophe Fouquet said in the ⁠2025 report. * In the 2024 report, CFO Roger Dassen had described AI as"a growth driver" that was not benefiting all customers equally. * "We anticipate continued growth in ⁠the ‌semiconductormarket driven by strong demand for AI ‌logic and memory products,along with high pricing resulting ⁠from supply-demand imbalances.This is expected to drive demand for growth in the equipmentmarket," the company said in 2025. * Elsewhere in the 2025 report ASML noted thatexport-control regimes continued to evolve in 2025, with theDutch government adding new controls on ​metrology and inspectionequipment in January. * In the 2025 report ASML also noted that it plans to set upa ​sales and support operation ‌in India.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Westinghouse Air Brake Technologies Insider Sold Shares Worth $9,831,177, According to a Recent SEC Filing
Westinghouse Air Brake Technologies Insider Sold Shares Worth $9,831,177, According to a Recent SEC Filing
Apr 7, 2025
12:15 PM EDT, 04/07/2025 (MT Newswires) -- Rafael Santana, Director, President and CEO, on April 03, 2025, sold 55,942 shares in Westinghouse Air Brake Technologies ( WAB ) for $9,831,177. Following the Form 4 filing with the SEC, Santana has control over a total of 145,616 common shares of the company, with 145,616 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/943452/000094345225000106/xslF345X05/wk-form4_1744042154.xml Price:...
--Entergy to Pay Quarterly Dividend of $0.60 a Share, Payable June 2 to Shareholders of Record May 2
--Entergy to Pay Quarterly Dividend of $0.60 a Share, Payable June 2 to Shareholders of Record May 2
Apr 7, 2025
12:14 PM EDT, 04/07/2025 (MT Newswires) -- Price: 78.36, Change: -0.67, Percent Change: -0.85 ...
Novo Nordisk to invest $1.09 billion to boost Ozempic, Wegovy production in Brazil
Novo Nordisk to invest $1.09 billion to boost Ozempic, Wegovy production in Brazil
Apr 7, 2025
SAO PAULO, April 7 (Reuters) - Novo Nordisk, the producer of Ozempic, Wegovy and other medications, will invest 6.4 billion reais ($1.09 billion) in Brazil to boost production, it said on Monday. The investment aims to increase manufacturing capacity at Novo Nordisk's facility in Minas Gerais state for injectable drugs for the treatment of obesity, diabetes and other serious chronic...
Copyright 2023-2026 - www.financetom.com All Rights Reserved